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Abstract 
Diabetes mellitus affects normal metabolizing body function and causes long term organs 
dysfunctions like blindness, kidney failure, neuropathy and autonomic dysfunction. The 
musculoskeletal is also affected by T2DM and causes pain, dysfunctions, and disabilities. 
Thus, this study is to find the prevalence of neuro-musculoskeletal complications in 
patients with T2DM. This cross sectional survey was conducted in various public and 
private sector hospitals of four major cities of Pakistan (Islamabad, Karachi, Lahore, and 
Sargodha) from 1st May to 31st December 2015. The patients of type II diabetes mellitus 
with both gender and age above 40 were included, and patients with active systemic 
disease of bones and soft tissues were excluded. A self-structured questionnaire was 
developed, reviewed by experts, and finalized after calculating their recommendations. 
The questionnaire was distributed among 600 patients, out of whom 500 patients 
responded. The non-probability convenient sampling technique was used for data 
collection. The data was analyzed by SPSS and percentages were calculated to estimate 
the neuro-musculoskeletal complications in patients with T2DM. 
The prevalence of neuro-musculoskeletal complication in type II Diabetes mellitus was 
100 %, while the frozen shoulder, tingling sensations and ants crawling sensations (61%) 
were equally the most common neuro-musculoskeletal complications followed by knee 
pain (53%), low back pain (43%).The most involved age group was 61 to 65 years and 
58% patients were with positive family history. The most commonly used way of 
treatment was medications (90%) and physical therapy (10%). It was proved in study that 
frozen shoulder, altered sensations, knee pain and back pain have high association with 
long duration of T2DM.There is association between long duration of diabetes mellitus 
and neuro-musculoskeletal complications. It is concluded that the prevalence of 
neuro-musculoskeletal complications is high among patients of T2DM and commonly 
affects shoulder, back, knee and altered sensation in legs. These are most commonly 
managed with medications followed by physical therapy.  
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1. Introduction 
Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia. DM 
patients have a lifelong or long-term disorder of high blood glucose level. High blood 
glucose level with disturbances of carbohydrate, fat, and protein metabolism causes 
defects in insulin secretion, insulin action, or both. . In 2013 it was statistically concluded 
that 382 million people with DM all over the world have high prevalence of T2DM .It is 
suspected that  592 million people  will die of DM in 2035 (Tao, Shi, & Zhao, 2015).  
DM genetically and hereditary belongs to heterogeneous group of disorders (Hussain, 
Hussain & Hussain, 2015). Endoplasmic reticulum is the main organ of body which 
control cellular hemostasis but due to some environmental factors ER function is 
depressed and causes pancreatic B cell destruction in T1DM and pancreatic B cell failure 
in T2DM.The pancreas does not make a hormone called insulin which help to regulate 
the glycaemia level in human body (Engin. 2016).  
Diabetes is the seventh most leading cause of death in the United States. It is a chronic 
and constant disease which poses a major threat to human population. DM greatly affects 
young population particularly in developing countries due to poor socioeconomic status, 
education, and lack of awareness. Currently, Around 180 million people are affected  by 
diabetes and according to researchers, by 2015 it will multiplied (American Diabetes 
Association. 2013).  
  
  
 
Figure 1: Projection graph in five countries reflecting increase of Diabetes 
 
Prevalence of diabetes in India, Pakistan, Bangladesh, China and US by 2030 (Ansari, 
Dixon, & Coles, 2015). Pakistan stands on 7th   in the prevalence list with 7 million DM 
patients.  
Type 1 DM is an Insulin dependent DM and is also known as Juvenile DM. It has an 
abrupt onset of clinical symptoms. The patient of type 1 DM depends upon insulin. It is 
affected by genetic and environmental factors. Genetically onset of type 1 DM is affected 
by the increase and decrease of histocompatibility antigen (HLA) on chromosome 6 
(Nerup et al., 1976). Environmental factors may affect people directly by B cell toxicity 
and by stimulating the autoimmune reactions against the B cell. Type 1 DM is also 
affected by different viruses(mumps, retroviruses), chemical substances and dietary 
components(mumps, retroviruses) (Purohit, Sharma, & She, 2015). T1DM patients have 
progressive B cell destructions, which cross a certain threshold level at which adequate 
insulin secretion level cannot maintain for a longer period and increase the rate of 
mortality in T1DM (Snell-Bergeon, & Maahs, 2015).  
Type II DM is also known as noninsulin- dependent diabetes mellitus. It is one of the 
chronic health problems all over the world. Type II DM is a cause of death and disability 
  
  
due to their chronic complications. It is evaluated that that by 2030 adults suffering from 
T2DM may rise to 439 million (Liu et al., 2010). Patients of this type of diabetes do not 
require insulin to sustain their life, in order they require insulin for the prevention of 
ketoacidosis and symptoms which cannot be achieved by the diet and drugs. Patients 
having non-insulin dependent diabetes may be asymptomatic or may exhibit slow 
progression of clinical symptoms. 
T2DM is a hereditary disease which causes life time neuro-musculoskeletal 
complications. It requires treatment and self-management. Family history and obesity is 
usually a positive factor in T2DM (Cederberg, et al., 2015). T2DM mostly occurs after 
the age of 40 but in rare cases it may affects young population. Genetically it is 
autosomal dominant inheritance. T2DM is mostly present in obese patients (National 
Diabetes Data Group, 1979).  
Reduction in the total mass of pancreatic islet is a hallmark of T2DM. Brain derived 
neurotrophic factor (BDNF) is associated with the development of T2DM. If serum 
BDNF is low, it causes obesity and impaired glucose metabolism (Li, Lang, & Cheng, 
2015). Recent researchers conclude that low socio-economic status, aggressive behavior, 
mental health problems and social disparities causes T2DM (Kelly & Ismail, 2015). 
People who have impaired fasting glucose are at a highest risk for non-insulin dependent 
diabetes (Rimm, et al., 1995).  
 
Table 1: Contrasting Types 1 DM and Type II DM 
 Type 1 DM                                   Type II DM 
onset of age <40 >40 
Duration of symptoms Weeks Months or years 
  
  
Body weight Low or normal Obese 
Ketonuria Yes No 
Prevalence of death  Yes  No 
Autoantibodies Positive Negative 
Diabetic complications No Yes 
Family history No Yes 
Other disease prevalence  Common Uncommon 
 
DM is a chronic condition. The growth rate of people with diabetes is increasing day by 
day due to unhealthy life style, uprising population, obesity, and depression and 
ultimately requires management (Semenkovich et al., 2015). Diet and exercise plans are 
helpful in the prevention of cardiovascular problems associated with diabetes (Balk et al., 
2015). Nowadays Glucagon-like peptide-1 (GLP-1) analog liraglutide is used for DM 
treatment because with anti-diabetic medicine it maintain the glycaemia level very 
efficiently and are safe and tolerable (Petri, Jacobsen, & Klein, 2015). When conventional 
therapy diet, exercise and weight loss does not produce significant effect in controlling 
glucose level then aggressive weight loss treatment plan is used and oral anti diabetic 
drugs are used (Scheen, 2015).  
This disease  occur due to  hyperglycemia that  causes long term  organs 
dysfunction , blindness, neuropathy with the risk of foot ulcers which leads to  
amputation, Charcot joints, and features of autonomic dysfunction including sexual 
  
  
dysfunction. People with diabetes are at increased risk of cardiovascular problems, 
kidney failure, peripheral vascular and cerebrovascular disease (Gautam, 2014). 
Complications commonly occur in T2DM patients are as following: 
 
1.1 Diabetic polyneuropathy (DPN) 
Diabetic polyneuropathy is a common complication of DM. In this, patient suffer with 
muscle weakness, muscles atrophy, less contractile property of muscle but increase 
antagonist muscle contraction and many neurological problems. It is mostly caused by 
alpha motor neuron dysfunction and changes in muscle fibers. Muscles strength is loss, 
planter flexion and dorsiflexion power is reduced in DPN. Smoking, abnormal glucose 
control, females, long duration of DM and retinopathy are the risk factors of DPN. 
Normal muscle  mass and contractile property of muscle is reduced (Moore, 2015).  
 
1.2 Frozen shoulder  
Frozen shoulder is the most common complication of diabetes. Frozen shoulder is 
dependent upon patient age and duration of DM. In frozen shoulder, both active and 
passive range of motion is limited. It is classified as (i) primary, in which etiology of 
restricted range of motion is not known and (ii) Secondary, in which etiology is known. 
Main causes of frozen shoulder are (i) Intrinsic causes mean ROM is restricted due to any 
rotator cuff muscle. (ii) Extrinsic causes include any surgery of chest wall, cervical 
radiculopathy. (iii) Systemic causes include any systemic disease like DM. In frozen 
shoulder all ROM is restricted but extension and external rotation movement is more 
affected. Patient also feels pain in all movements of shoulder. Daily life routine of patient 
is disturbed; he is not able to do his routine works. According to previous studies frozen 
shoulder have high prevalence in diabetic patients (Angelo, et al., 2015).  
Frozen shoulder patient has limited range of motion and face problems in the completion 
of their routine works. With the passage of time many advance treatments are developed 
  
  
for the management of frozen shoulder. Suprascapular nerve block is used for the pain 
reduction and restore of active range of motion (Mortada, 2015). Frozen shoulder is 
treated affectively with pregabalin, glucocorticoid therapy and  physiotherapy exercise 
plan (Canbulat, 2015).  
 
1.3 Back pain  
Low back pain has a high prevalence in diabetic patients which is increasing day by day 
and current researches also prove it. According to study, back pain has high prevalence in 
diabetic patients than non-diabetic patients which is found to be 46.2% (Idowu, 2015). 
1.4 Knee pain 
Diabetes is caused by obesity and obesity is the risk factor for the development of 
osteoarthritis which is the leading cause of knee pain in DM patients. Studies prove that 
diabetes reduces the joint space in knees which causes pain (Eymard, 2015).  
Literature review 
Around the globe type 2 DM is found to be a major chronic disease (Cadliero, 2002). It 
was estimated in 2011 that 14 million people were suffering from DM in Africa and will 
increase by double in 2030 (Burner, 2009). In addition type to DM is more commonly 
seen in urban areas in contrast to rural areas (Grey A. Delbeth 2003). The principle risk 
factor that exacerbates type 2 DM among population is thought to be physical activities, 
diet and aging. High-calories fatty diet with minimum or no physical activity is a major 
cause of obesity (Smith, 2003). In addition, obesity impedes glucose tolerance leading to 
increase chance of diabetic manifestation (Kapoor, 2003).  
To reduce the complication of type 2 DM, sustain glycaemia level should be ensured 
(Andersom, 2007). According to UK Prospective diabetes study (UKPDS) 1% reduction 
was seen in glycaeted HbA1c which was associated with 37% decrease in neural and 
14% decrease in muscular complication (Kapoor, 2003). As evaluated from 10 years 
follow-up study, individuals (with type 2 DM) that maintain their glycaemia level 
  
  
experience benefit many years later that includes reduce chances of neuromuscular 
complication and diabetes-related death (Makita 1991). The etiology of neuromuscular 
complication is not clearly understood (Burner 2009). Individuals with poor glyacemia 
control are associated with increase prevalence of neuromuscular complication (Cadliero, 
2002). These neuromuscular complications are widespread and are common cause of 
sickness (Makita, 1991). 
T2DM is a hereditary disease which causes life time neuro-musculoskeletal 
complications. It requires treatment and self-management. Family history and obesity is 
usually a positive factor in T2DM (Cederberg, et al., 2015). T2DM mostly occurs after 
the age of 40 but in rare cases it may affects young population. Genetically it is 
autosomal dominant inheritance. T2DM is mostly present in obese patients (National 
Diabetes Data Group, 1979).  
Reduction in the total mass of pancreatic islet is a hallmark of T2DM. Brain derived 
neurotrophic factor (BDNF) is associated with the development of T2DM. If serum 
BDNF is low, it causes obesity and impaired glucose metabolism (Li, Lang, & Cheng, 
2015). Recent researchers conclude that low socio-economic status, aggressive behavior, 
mental health problems and social disparities causes T2DM (Kelly & Ismail, 2015). 
People who have impaired fasting glucose are at a highest risk for non-insulin dependent 
diabetes (Rimm, et al., 1995).  
 
Type 1 DM is an Insulin dependent DM and is also known as Juvenile DM. It has an 
abrupt onset of clinical symptoms. The patient of type 1 DM depends upon insulin. It is 
affected by genetic and environmental factors. Genetically onset of type 1 DM is affected 
by the increase and decrease of histocompatibility antigen (HLA) on chromosome 6 
(Nerup et al., 1976). Environmental factors may affect people directly by B cell toxicity 
and by stimulating the autoimmune reactions against the B cell. Type 1 DM is also 
affected by different viruses(mumps, retroviruses), chemical substances and dietary 
  
  
components(mumps, retroviruses) (Purohit, Sharma, & She, 2015). T1DM patients have 
progressive B cell destructions, which cross a certain threshold level at which adequate 
insulin secretion level cannot maintain for a longer period and increase the rate of 
mortality in T1DM (Snell-Bergeon, & Maahs, 2015).  
Type II DM is also known as noninsulin- dependent diabetes mellitus. It is one of the 
chronic health problems all over the world. Type II DM is a cause of death and disability 
due to their chronic complications. It is evaluated that that by 2030 adults suffering from 
T2DM may rise to 439 million (Liu et al., 2010). Patients of this type of diabetes do not 
require insulin to sustain their life, in order they require insulin for the prevention of 
ketoacidosis and symptoms which cannot be achieved by the diet and drugs. Patients 
having non-insulin dependent diabetes may be asymptomatic or may exhibit slow 
progression of clinical symptoms. 
T2DM is a hereditary disease which causes life time neuro-musculoskeletal 
complications. It requires treatment and self-management. Family history and obesity is 
usually a positive factor in T2DM (Cederberg, et al., 2015). T2DM mostly occurs after 
the age of 40 but in rare cases it may affects young population. Genetically it is 
autosomal dominant inheritance. T2DM is mostly present in obese patients (National 
Diabetes Data Group, 1979).  
  
2. Materials and methods 
2.1 Study design: 
Cross sectional survey because the study is an attempt to investigate within six months 
timeframe (Zehra, et al., 2017).  
2.2 Setting 
The study was conducted in public and private hospitals of four major cities (Lahore, 
Karachi, Islamabad, and Sargodha) of Pakistan. 
2.3 Duration of study  
  
  
The duration of the study was from 1st May to 31st December 2015. 
2.4 Sample size and sampling technique 
Total 500 patients were included in the study. The Non probability convenient sampling 
technique was used to collect data.   
2.5 Sample selection 
2.5.1 Inclusion criteria 
Type II DM patients  
Having age above than 40 
Both genders male and females 
2.5.2 Exclusion criteria: 
Type I DM patients 
Age below 40 
History of trauma 
Patient having DM but complication develop after fracture  
Dislocations  
Malignancy 
Autoimmune disease 
Other systemic problems 
Prior history of any neuromuscular condition 
 
         All the patients who have T2DM with the positive family history were 
included in the study. The patients who have another systemic disease, fracture, trauma 
etc were excluded. The demographic data i.e. age, gender, sugar level were noted. This 
helps in data reliability, credibility, and validity (Haque & Yamoah, 2014; Haque & Aston, 
2016). Data was collected from private and public hospitals of four major cities of 
Pakistan (Islamabad, Sargodha, Karachi, and Lahore). The data were collected after 
taking the consent from the patients. 
  
  
A self-structured pre-tested questioner was used to collect the data. It was a 
non-probability convenient sampling study to find out the prevalence of 
neuro-musculoskeletal complications in T2DM. Questionnaires were distributed among 
600 patients in whom 500 patients responded. 51.4% females and 48.6% males 
participated in the study. Patients having age above 45 years were included. Age group 
61-65 years with history of DM for more than 3 years was more affected and show high 
prevalence for neuro-musculoskeletal complications. Data was analyzed on SPSS version 
and percentages were calculated to estimate the neuromuscular skeletal complications in 
patients with T2DM. 
3. Results 
The prevalence of neuro-musculoskeletal complication in type II Diabetes mellitus was 
100 %, while the frozen shoulder, tingling sensations and ants crawling sensations (61%) 
were equally the most common neuro-musculoskeletal complications, followed by knee 
pain (53%), low back pain (43%).These complications have high associations with long 
duration of T2DM. The most involved age group was 61 to 65 years and 58% patients 
were with positive family history. The most commonly used way of treatment was 
medications (90%) and physical therapy (10%). It was proved in study that frozen 
shoulder, altered sensations, knee pain, and back pain have high association with long 
duration of T2DM. 
  
  
 
Figure 2: Percentage of the Gender of the Patients Nominal  
The above graph shows that 51.4% Females and 48.6% Males participated in the study. 
 
Figure 3: Age of participants 
The above graph shows that the % of the  patients with the age group  of 30-35 years 
are 1.8%, 36-40 years are 1.8%,  41-45 years are 11.6%, 46-50 years  are 12.6%, 51-55 
years  are 16.8%, 56-60 years are 13.8%, 61-65 years are 17.0%, 66-70 years  are 5.4%, 
71-75 years  are 7.4% and   76-80 years are 11.8%. 
  
  
 
Figure 4: Participants' sugar level 
The graph shows that  the % of  patients having  sugar level  group of 50-100 are 
0.6%, 101-150 are 7.6%, 151-200 are 14.2%, 201-250 are 9.4%, 251-300 are 43.4, 
301-350 are 14.6, 351-400 are 2.6 and sugar level  group of 401-450 are 7.6%. 
 
Figure 5: Family hisotry of participants 
The graph shows that 58.2% people have family history of diabetes while 41.8% shows 
no positive family history. 
  
  
 
Figure 6: Frozen shoulder percentages 
The above graph shows that 61.2% patients say that they have frozen shoulder while 
38.2% says they do not have frozen shoulder. 0.6% patients do not respond to this 
question. 
 
Figure 7: Percentages of feeling like ant crawling 
 
The graph shows that 61.2% patients feel ants crawling sensations while 38.8% don’t 
feel. 
 
  
  
 
Figure 8: Percentage of Knee Pain or Stiffness 
The above graph shows that 53.4% patients feel pain or stiffness in knee while 45.6% 
don’t feels pain. 1.0%% don’t respond to this question. 
 
 
Figure 9: Percentage of Back pain or Stiffness 
Graph shows that 42.6% people say that they feel stiffness and back pain while 57.4% 
says that they don’t feels stiffness and back pain. 
These complications have association with long duration of T2DM. 
4. Discussion 
The aim of the current study was to investigate the prevalence of common 
  
  
neuro-musculoskeletal complications in T2DM .The total participants were 500. The 
result shows high prevalence of neuro-muscular skeletal complications inT2DM patients. 
Mostly patients have positive family history of diabetes. Age groups of 61-65 years were 
affected mostly having sugar level 251-300 and have T2DM more than 3 years ago. 
Moreover, 90% patients use allopathic medicines but mostly patients have fluctuations in 
blood pressure besides the use of medicines. The prevalence of neuro-musculoskeletal 
complication in type II Diabetes mellitus was 100 %, while the frozen shoulder, tingling 
sensations and ants crawling sensations (61%) were equally the most common 
neuro-musculoskeletal complications, and followed by knee pain (53%), low back pain 
(43%). Long-term duration of T2DM shows high prevalence with frozen shoulder, altered 
sensations, knee pain and back pain. 
 
Long duration T2DM develop peripheral neuropathy. It causes alternate sensations 
especially in lower limbs which causes foot ulcer and lead to amputations. Recent studies 
showed that neuropathic changes occur in the early stage of diabetes. Age, long duration 
of diabetes and abnormal glucose level are the main risk factors for the development of 
peripheral neuropathy. In a previous study it shows that patient have DM <5 year shows 
20.8% prevalence which increases to 36.8% prevalence with duration >10 years (Lee, 
2015). Current study also proves that peripheral neuropathy prevalence is high with long 
duration of diabetes, which is 61%. 
T2DM rate is increasing day by day due to sedentary life style, lack of awareness of 
self-management and inadequate nutrition. It showed that neuropathy had high 
prevalence in neuro-musculoskeletal complications (Sosale et al., 2016). Current study 
also shows that neuropathy have high prevalence which is 61%. 
Another study says that T2DM patients have high prevalence of neuropathy which is 
13.2% which is followed by retinopathy 5.1% and nephropathy which is 0.9% smoking, 
hyperglycemia are risk factors for the development of neuropathy complications 
  
  
(Plancher & Petterson, 2016). Current study also proves that neuropathy have high 
prevalence which is 61 %. 
Frozen shoulder is normally present in population but its incidence rate is increased to 10 
-15% in diabetic population. It is a common musculoskeletal complication of DM 
patients. Many previous studies prove its high prevalence in diabetes. According to one 
study frozen shoulder has high prevalence in diabetic, female gender age above than 40 
(Angelo et al., 2016). Current study highlights that frozen shoulder have highest 
prevalence (61%) with female gender and age between 61-65 years. 
Frozen shoulder in T2DM patients have a prevalence of 22.4% which is higher than 
T1DM patients which is 10.3% (Fatemi et al., 2015). Current study shows the same 
results that T2DM patients have high prevalence of frozen shoulder. 
Another study shows that 88 patients of frozen shoulder have no previous known positive 
history of diabetes but blood sample proves that they have diabetes and show prevalence 
of 38.6% which is higher than non-diabetic frozen shoulder patients (Shah et al., 2015). 
Interestingly, patients has affected from occupational stress that deteriorate their health 
(Haque et al., 2016).   
Different studies prove that diabetic patients are mostly older age and they have at least 
one co-morbid. One study shows that knee osteoarthritis and shoulder complication have 
high prevalence in diabetic patients than non-diabetic patients (Pai et al., 2015). Present 
study shows that shoulder and knee complications have high prevalence which is 61% 
and 53% respectively. 
A research shows that diabetic patients have impaired sensations, limited range of motion 
of shoulder and hands less pinch grip of hand as compared to the non-diabetic patients. 
Present study shows that 63% patients have shoulder pain and limited joint range of 
motion (Pai et al., 2015). Recent study also shows that frozen shoulder and altered 
sensation have high prevalence in diabetic patients. 
T2DM patients have sedentary life style; they are mostly inactive and obese and have 
  
  
many complaints of musculoskeletal pains. According to one study T2DM patients have 
higher mean visits to doctor for muscular pain than non-diabetic patients (Emyard, et al., 
2015). Current study proves that T2DM patients have more frozen shoulder 61%, knee 
pain 53% and back pain 43 %. 
T2DM causes less joint space in knee. Due to less joint space patients feel pain. A 
previous study shows that T2DM causes less joint space in knee joint of obese DM 
patients than non-diabetic patients which is (0.26 [−0.35 to −0.17] vs 0.14 [−0.16 
to −0.12] mm; P = 0.001) (Idowu, et al., 2015). Current study shows that T2DM patients 
are more affected with knee joint pain which have 53% prevalence.  
T2DM patients are more affected with chronic low back pain. Previous studies  proves 
that DM have a high prevalence of low back pain than non-diabetic patients which is 
41.3% (Yurdakul, et al., 2015). Present study shows high prevalence of back pain which 
is 43%.  
T2DM have a high prevalence of neuropathy complications. Previous studies prove that it 
causes altered sensations in hands like carpel tunnel syndrome. Perkins et al reported that 
CTS is common in 30% diabetic neuropathy (Alonso-Morán, 2015). Current study shows 
that diabetic neuropathy have a high prevalence which is 61%. 
T2DM patients have many complications at a time. There isn’t any single person in this 
world that has no complication after the development of diabetes. According to study 
92% females have multi morbidity due to T2DM (Baba et al., 2015). Present study shows 
100% prevalence of complications in T2DM patients. 
A study show high prevalence for foot ulcer and diabetic foot. Long duration of diabetes 
and polyneuropathy cause high prevalence of foot ulcer (Magnusson et al., 2015). Current 
study show only 40% prevalence of foot ulcer and diabetic foot which is less than frozen 
shoulder prevalence. 
A previous study shows that diabetic patients, female gender, age above than 45 have 
hand pain due to Diabetes (Ranger et al., 2015). Current study show less prevalence of 
  
  
wrist and finger pain in T2DM which is 18% and 13% respectively. 
Previous studies shows high prevalence or association of diabetes and elbow pain and 
tendinopathy (Ranger et al., 2015). Current study show only 16% prevalence of elbow 
pain. 
5. Conclusion & Recommendations 
It is concluded that the prevalence of neuro-musculoskeletal complications is high among 
patients of T2DM and commonly affects shoulder, back, knee and altered sensation in 
legs. These are most commonly managed with medications and followed by physical 
therapy. In addition to that, the stress among patient is one of the contribution factor 
enhancing different types of pain and anxiety. It is recommended to conduct further 
studies on the topic with large sample size across the country to further investigate the 
prevalence of neuro-musculoskeletal complications. 
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